Evidence map›Paper›PMID 38671058›Full record

ArticleScientific reports2024

Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic.

Anne Russcher, Michiel van Boven, Elisa Benincà, E J T Joanne Verweij, Marijke W A Molenaar-de Backer, Hans L Zaaijer, Ann C T M Vossen, Aloys C M Kroes

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Human parvovirus B19 infection in a Spanish healthcare area: epidemiology, clinical spectrum, and factors associated with hospitalization.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Complex multiannual cycles ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Parvovirus: Conservative management of fetal anemia and hydrops.Acta obstetricia et gynecologica Scandinavica · 2025
    Review
  7. Article
  8. Is parvovirus B19 infection upsurge in 2023-2024 associated with adverse pregnancy outcome?Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ongoing outbreak of maternal parvovirus B19 infections in Germany since end of 2023: consequence of COVID-19 pandemic?Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Anne RusscherLUCID Medical Microbiology and Infection Control, Leiden University Medical Center, Leiden, The Netherlands. a.russcher@lumc.nl.ORCID http://orcid.org/0009-0009-2186-5410
Michiel van BovenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID http://orcid.org/0000-0002-0841-2400
Elisa BenincàCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID http://orcid.org/0000-0002-9261-9315
E J T Joanne VerweijDepartment of Obstetrics, Division of Fetal Therapy, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-9343-9957
Marijke W A Molenaar-de BackerDepartment of Blood-Borne Infections, Donor Medicine Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-3604-6097
Hans L ZaaijerDepartment of Blood-Borne Infections, Donor Medicine Research, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0773-7315
Ann C T M VossenLUCID Medical Microbiology and Infection Control, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-1750-2843
Aloys C M KroesLUCID Medical Microbiology and Infection Control, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-9866-2461
Leiden University Medical Center · NLSanquin · NLNational Institute for Public Health and the Environment · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parvovirus B19V (B19V) infection during pregnancy can be complicated by potentially life-threatening fetal hydrops, which can be managed by intrauterine transfusion (IUT). This study investigates the long-term temporal patterns in the epidemiology of B19V and evaluates the impact on fetal hydrops, by combining data on B19V infections from the Dutch Sentinel Surveillance system in the period 1990 to 2023, Dutch blood banking data and hospital data on fetal hydrops. Using wavelet analysis, we identified annual epidemic cycles in the Netherlands in the period 1990-2019 and we identified superimposed multiannual cycles in the period 1990-2009. After 2009, no multiannual cycle could be identified, although the incidence fluctuated and correlates with number of IUT performed. As of 2020, weekly reports of B19V infection demonstrated a historically low incidence and B19V-DNA positive blood donors were nearly absent. From May 2020 to May 2023, no IUT for B19V-related hydrops was performed. In the spring of 2023, B19V infections re-emerged, reaching pre-pandemic epidemic levels. Due to the changes in B19V epidemiology over the last 30 years and the near-absence of B19V during the COVID-19 pandemic, the resulting low immunity levels may lead to rebound outbreaks. Alertness to severe complications such as fetal hydrops is warranted.

Indexed as

COVID-19Hydrops FetalisParvovirus B19, HumanAdultBlood Transfusion, IntrauterineErythema InfectiosumFemaleHumansIncidenceNetherlandsPandemicsParvoviridae InfectionsPregnancyPregnancy Complications, InfectiousSARS-CoV-2

Identifiers

PMID38671058
PMCPMC11053065
OpenAlexW4395664877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.